These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 755245)

  • 1. On the mechanisms of hypotensive action of indoramin.
    Gulati K; Srimal RC; Dhawan BN
    Pol J Pharmacol Pharm; 1978; 30(6):811-8. PubMed ID: 755245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of clonidine on the excitability of vasomotor loci in the cat.
    Dhawan BN; Johri MB; Singh GB; Srimal RC; Viswesaram D
    Br J Pharmacol; 1975 May; 54(1):17-21. PubMed ID: 1139074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation into the cardioregulatory properties of the alpha 1-adrenoceptor blocker indoramin.
    Pierce V; Shepperson NB; Todd MH; Waterfall JF
    Br J Pharmacol; 1986 Feb; 87(2):433-41. PubMed ID: 3955309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations into the bradycardic action of indoramin.
    Lillie C; Harron DW; Kobinger W
    Arzneimittelforschung; 1985; 35(1A):301-5. PubMed ID: 4039170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of serotonin-1A receptor activation and alpha-1 adrenoceptor blockade in the hypotensive effect of 5-methyl-urapidil.
    Mandal AK; Kellar KJ; Gillis RA
    J Pharmacol Exp Ther; 1991 May; 257(2):861-9. PubMed ID: 1674536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The central actions of nicotine on blood pressure and heart rate after administration via the left vertebral artery of anaesthetized cats. Distribution of nicotine into the brain after central application.
    Porsius AJ; Van Zwieten PA
    Arzneimittelforschung; 1978; 28(9):1628-31. PubMed ID: 582567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central and peripheral contribution to the antihypertensive action of indoramin.
    Baum T; Shropshire AT
    Eur J Pharmacol; 1975 May; 32(1):30-8. PubMed ID: 168091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of intracerebroventricularly injected CDP-choline in normotensive and hypotensive animals: the involvement of cholinergic system.
    Savci V; Cavun S; Goktalay G; Ulus IH
    Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):388-98. PubMed ID: 12012025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cardiovascular effects of centrally and peripherally administered indoramin in conscious rats.
    Porter JP; Bonham AC; Mangiapane ML; Webb RL; Brody MJ
    Eur J Pharmacol; 1985 Feb; 109(1):9-17. PubMed ID: 3996469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Centrally mediated hypotensive effect of E coli endotoxin in the anesthetized cat.
    Koyama S; Santiesteban HL; Ammons WS; Manning JW
    Circ Shock; 1982; 9(6):557-70. PubMed ID: 6758978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of enkephalins on central processes regulating hemodynamics].
    Medvedev OS; Val'dman AV; Titov MI
    Biull Eksp Biol Med; 1981 May; 91(5):574-6. PubMed ID: 7260388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventrolateral medulla: an important site of action for the hypotensive effect of drugs that activate serotonin-1A receptors.
    Mandal AK; Zhong PY; Kellar KJ; Gillis RA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S49-60. PubMed ID: 1702487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological studies on 2-(2-(4-(3-methylphenyl)-1-piperazinyl)ethyl) quinoline (centhaquin). I. Hypotensive activity.
    Srimal RC; Gulati K; Nityanand S; Dhawan BN
    Pharmacol Res; 1990; 22(3):319-29. PubMed ID: 2367281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cocaine acts in the central nervous system to inhibit sympathetic neural activity.
    Raczkowski VF; Hernandez YM; Erzouki HK; Abrahams TP; Mandal AK; Hamosh P; Friedman E; Quest JA; Dretchen KL; Gillis RA
    J Pharmacol Exp Ther; 1991 Apr; 257(1):511-9. PubMed ID: 2020007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interaction with gamma-aminobutyric acid/benzodiazepine receptors at the ventral surface of the medulla results in pronounced changes in cardiorespiratory activity.
    Gillis RA; Namath IJ; Easington C; Abrahams TP; Guidotti A; Quest JA; Hamosh P; Taveira da Silva AM
    J Pharmacol Exp Ther; 1989 Feb; 248(2):863-70. PubMed ID: 2537419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system site of action of capsaicin-induced cardiovascular changes in the cat.
    Quest JA; Dias-Souza J; Norman WP; Holtman JR; Gillis RA
    J Pharmacol Exp Ther; 1984 Mar; 228(3):719-24. PubMed ID: 6707921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a central sympathoinhibitory action of prazosin and indoramin.
    Ramage AG
    Eur J Pharmacol; 1986 Feb; 121(1):83-9. PubMed ID: 3956575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Centrally mediated hypotension and bradycardia induced by an aminotetralin derivative: TL-68.
    Sharabi FM; Long JP; Rusterholz DB; Hoffman WE; Lee T; Cannon GJ
    Res Commun Chem Pathol Pharmacol; 1978 Jun; 20(3):457-73. PubMed ID: 674826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation into mechanism of lack of reflex tachycardia in response to hypotensive action of indoramin in dogs.
    Harron DW; Kerr MJ; Shanks RG
    J Cardiovasc Pharmacol; 1984; 6(4):596-600. PubMed ID: 6206312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central sympathetic reactivity inhibited by indoramin.
    Davison M; Koss M
    Eur J Pharmacol; 1980 Nov; 68(2):193-6. PubMed ID: 7202486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.